Related Experiment Videos
Organizational issues in conducting tuberculosis screening at a syringe exchange program
D Paone1, D C Perlman, M P Perkins
1Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA. dpaone@ix.netcom.com
Journal of Substance Abuse Treatment
|June 20, 1998
Summary
Injecting drug users face high risks for tuberculosis (TB) and human immunodeficiency virus (HIV). A syringe exchange program in New York City piloted TB screening and preventive therapy for this population.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Rising tuberculosis (TB) cases in the US are linked to human immunodeficiency virus (HIV).
- Injecting drug users (IDUs) in New York City have high rates of HIV (40%) and TB (4x national average).
- IDUs have a high prevalence of latent TB infection and are at increased risk for active TB and HIV.
Purpose of the Study:
- To evaluate the feasibility of TB screening and directly observed TB preventive therapy.
- To implement these services for active injecting drug users at a syringe exchange program.
- To identify general and operational issues in integrating medical and public health services into drug-using focused programs.
Main Methods:
- Conducted TB screening and directly observed TB preventive therapy.
- Services were offered to active injecting drug users at a syringe exchange program in New York City.
- Documented implementation issues and operational challenges.
Main Results:
- The study assessed the feasibility of integrating TB services within a syringe exchange program.
- Identified key implementation and operational considerations for serving IDUs.
- Highlighted the need for accessible TB care for high-risk populations.
Conclusions:
- Integrating TB screening and preventive therapy into syringe exchange programs is feasible.
- Such integration can address critical public health needs for injecting drug users.
- This approach facilitates access to care for a vulnerable population at high risk for HIV and TB.